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METHODS, SYSTEMS, AND DEVICES FOR
PAIRING VAGUS NERVE STIMULATION
WITH MOTOR THERAPY IN STROKE
PATIENTS
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application is a continuation application of U.S.
patent application Ser. No. 13/651,349, filed on Oct. 12,
2012, entitled Methods, Systems, and Devices for Pairing
Vagus Nerve Stimulation with Motor Therapy in Stroke
Patients, naming Michael Kilgard and others as inventors,
which claims the benefit of U.S. Provisional Patent Appli-
cation No. 61/699,470, filed Sep. 11, 2012, U.S. Provisional
Patent Application No. 61/614,369, filed Mar. 22, 2012, U.S.
Provisional Patent Application No. 61/598,185, filed Feb.
13, 2012, U.S. Provisional Patent Application No. 61/558,
287, filed Nov. 10, 2011, and U.S. Provisional Patent Appli-
cation No. 61/627,532,filed Oct. 13, 2011. This application
is also a Continuation-In-Part of U.S. patent application Ser.
No. 13/095,570, filed Apr. 27, 2011, which claims the benefit
of U:S. Provisional Patent Application No. 61/328,621, filed
Apr. 27, 2010 and which is a Continuation-In-Part of U.S.
patent application Ser. No. 12/485,040, filed Jun. 15, 2009,
which claims the benefit of: U.S. Provisional Patent Appli-
cation No. 61/077,648, filed Jul. 2, 2008; U.S. Provisional
Patent Application No. 61/078,954, filed Jul. 8, 2008; U.S.
Provisional Patent Application No. 61/086,116,filed Aug. 4,
2008; and U.S. Provisional Patent Application No. 61/149,
387, filed Feb. 3, 2009. All of these applications are incor-
porated herein by reference as if reproduced in their entirety.
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND
Stroke is a leading cause of adult disability in the United
States, with upper motordeficits being the primary result of
the disability. These motor disabilities greatly affect quality
of life for the patient and their loved ones. In addition, the
loss of motor function exacts a financial toll on the health-
care system of nearly $70 billion yearly. Patients with
hemiplegia or hemiparesis generally regain walking without
the use of an assistive device while only half to one-third of
patients regain some degree of use of their upper extremity,
even after intensive rehabilitation therapy. The severe func-
tional impairment affects occupational performance, and as
a result, few stroke victimsare able to return to work. Upper
limb motor disabilities from stroke have an unfavorable
effect on the activities of daily living critically affecting the
quality of life for the stroke victim as well as family
members and caregivers.
Physical rehabilitation can result in significant improve-
ments in motor outcomes after stroke. Improvements in
recovery of upper extremity function have also been
reported for electromyographic feedback, motor imagery,
robotics, and repetitive task practice, though large scale
clinicaltrials have yet to be implemented. Unfortunately for
most patients, the gains are not enough to have a large
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impact on daily living. Further, current rehabilitative thera-
pies, such as constraint-induced movement therapy, are
restricted to individuals with mild to moderate deficits. Few
options are available for those stroke survivors with mod-
erate to severe deficits. Therefore, there is still a tremendous
need for methods that improve recovery of function even
further.
To enhance recovery further, adjuvant therapies have been
tried. For example, amphetamines can be effective at
enhancing recovery of motorabilities beyond that seen with
physical rehabilitation alone; however, even the positive
results for motor outcomes are only incremental, and
amphetamine use has many well-knownside effects. Several
small, randomized controlled trials have shownthat epidural
stimulation significantly improves motor recovery in animal
models and in human stroke survivors. Unfortunately, the
method requires brain surgery associated with the potential
for significant complications and is not likely to reach
widespread clinical use in stroke patients. Also, a recent
randomized clinical trial failed to demonstrate improved
efficacy compared with intensive physical rehabilitation.
Less invasive methods for cortical stimulation have also
been combined with physical rehabilitation. Again, how-
ever, while real gains in function are observed, the gains are
modest, for the most part. Thus, a great needstill exists for
a method to improve motor function further.
Current rehabilitation techniques do not sufliciently
restore lost function in many individuals. Statistically sig-
nificant improvements to motor deficits can be induced even
several months after stroke. However, these improvements
do not consistently improve quality of life for the vast
majority of patients and their caretakers, thus greater
improvements in motor skills are needed following reha-
bilitation.
Motor therapies typically involve practicing either fine
motor or gross motor skills. Repetition is generally the
mechanism of the therapies. In some variations, such as
constraint therapy and mirror therapy, other mechanismsare
engaged.
Some examples of typical motor therapies may be actions
such as: squeezing a dynamometer, turning on/off a light
switch, using a lock and key, opening and closing a door by
twisting or depressing different doorknobs, flipping cards,
coins and other objects over, placing light and heavy objects
at different heights, moving pegs to hole and remove pegs
from hole, lifting a shopping basket/briefcase, drawing
geometric shapes, dressing, typing, reaching and grasping
light and heavy objects, grasping andlifting different (size,
shape, and texture) objects, doing a precision grasp, writing,
drawing connect the dots, opening and closing a jar or
medication bottle, lifting an empty and full cup/glass, using
feeding utensils, cutting food, stirring liquids, scooping,
pouring a glass of water with the paretic hand; or using the
paretic handto stabilize the glass and pouring with the good
hand, picking an object and bring to target, using a spray
can, cutting with scissors, or brushing teeth/hair.
USS. Pat. No. 6,990,377 (Gliner,et al.) describes a therapy
to treat visual impairments. The therapy includes presenting
various types of visual stimuli in conjunction with stimula-
tion of the visual cortex. The therapy described in Gliner
does not control the timing relationship ofthe stimuli and the
stimulation.
U.S. Patent Application Publication 2007/1079534 (Fir-
lik, et al.) describes a therapy having patient interactive
cortical stimulation and/or drug therapy. The therapy has
patients performing tasks, detecting patient characteristics
and modifying the stimulation depending on the detected
US 9,522,272 B2
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patient characteristics. The therapy described in Firlik does
not control the timing relationship between the tasks and the
cortical stimulation.
Tt is commoninthepriorart to suggest that stimulation of
the cortex, the deep brain, the cranial nerves and the periph-
eral nerves are somehow equivalent or interchangeable to
produce therapeutic effects. Despite these blanket state-
ments, stimulation at different parts of the nervous system is
not equivalent. It is generally understood that the vagus
nerve is a nerve that performs unique functions through the
release of a wide array of neuromodulators throughout the
brain. To generate certain kinds ofplasticity, the timing of
the stimulation of the vagus nerve is critical in producing
specific therapeutic effects.
USS. Pat. No. 6,104,956 (Naritoku, et al.) is representative
of work done using vagus nerve stimulation (VNS)to treat
a variety of disorders, including epilepsy, traumatic brain
injury, and memory impairment. The VNS is delivered
without reference to any other therapy. To improve memory
consolidation, VNS is delivered several minutes after a
learning experience. Memory consolidation is unrelated to
the present therapy for treating motor deficits.
SUMMARY
For purposes of summarizing the disclosure, certain
aspects, advantages, and novel features of the disclosure
have been described herein. It is to be understood that not
necessarily all such advantages may be achieved in accor-
dance with any particular embodiment of the disclosure.
Thus, the disclosure may be embodied or carried out in a
mannerthat achieves or optimizes one advantage or group of
advantages as taught herein without necessarily achieving
other advantages as may be taught or suggested herein.
In an embodiment, the disclosure includes a method of
treating motordeficits in a stroke patient, comprising assess-
ing a patient’s motor deficits, determining therapeutic goals
for the patient, based on the patient’s motor deficits, select-
ing therapeutic tasks based on the therapeutic goals, per-
forming each of the selected therapeutic tasks repetitively,
stimulating the vagus nerve of the patient during the per-
formance of the selected therapeutic tasks, and improving
the patient’s motor deficits.
Ina second embodiment, the disclosure includes a method
of treating motor deficits in a stroke patient, comprising
assessing a patient’s motordeficits, determining therapeutic
goals for the patient, based on the patient’s motor deficits,
selecting therapeutic tasks based on the therapeutic goals,
performing each of the selected therapeutic tasks repeti-
tively, observing the performance of the therapeutic tasks,
initiating the stimulation of the vagus nerve manually at
approximately a predetermined moment during the perfor-
mance ofthe therapeutic tasks, stimulating the vagus nerve
of the patient during the performance of the selected thera-
peutic tasks, and improving the patient’s motordeficits.
In a third embodiment, the disclosure includes a method
of treating motor deficits in a stroke patient, comprising
assessing a patient’s motordeficits, determining therapeutic
goals for the patient, based on the patient’s motor deficits,
selecting therapeutic tasks based on the therapeutic goals,
performing each of the selected therapeutic tasks repeti-
tively, detecting the performance of the therapeutic task,
automatically initiating vagus nerve stimulation at a prede-
termined moment during the detected performance of the
therapeutic task, stimulating the vagus nerve of the patient
during the performanceofthe selected therapeutic tasks, and
improving the patient’s motor deficits.
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In a fourth embodiment, the disclosure includes a system
for providing therapy for a motor deficit, comprising, an
implantable stimulation system including an implantable
pulse generator (IPG), lead and electrodes to stimulate a
patient’s vagus nerve, a clinical controller with stroke
therapy software, an external communication device to
communicate between the clinical controller and the
implantable stimulation system, and a manual input device,
coupled to the clinical controller, wherein the manual input
device is engaged during performance of a therapeutic task
causing the clinical controller to send a signal using the
external communication device to the implantable stimula-
tion system, so that a patient’s vagus nerve is stimulated
during the performance of the therapeutic task.
Ina fifth embodiment, the disclosure includes a system for
providing automated therapy for a motordeficit, comprising,
an implantable stimulation system including an IPG, lead
and electrodes to stimulate a patient’s vagus nerve,a clinical
controller with stroke therapy software, an external commu-
nication device to communicate between the clinical con-
troller and the implantable stimulation system, and a motion
detection system, coupled to the clinical controller, wherein
the motion detection system detects performanceofa thera-
peutic task and at a predetermined time during the thera-
peutic task causing the clinical controller to send a signal
using the external communication device to the implantable
stimulation system, so that a patient’s vagus nerve is stimu-
lated during the performanceof the therapeutic task.
These andother features may be more clearly understood
from the following detailed description taken in conjunction
with the accompanying drawings and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
For a more complete understanding of this disclosure,
reference is now madeto the following brief description,
taken in connection with the accompanying drawings and
detailed description, wherein like reference numerals repre-
sent like parts.
FIG. 1 is a flowchart depicting a task selection and
therapy parameter selection process for a paired-VNS motor
therapy, in accordance with an embodiment;
FIG.2 is a flowchart depicting a setup and administration
process for a paired-VNS motortherapy, in accordance with
an embodiment;
FIG.3 is a flowchart depicting another setup and admin-
istration process for an automated paired-VNS motor
therapy protocol, in accordance with an embodiment;
FIG. 4 is a graph depicting the timing of a therapeutic
motion and examples of possible stimulation timing varia-
tions for paired VNS;
FIG. 5 depicts an implantable vagus nerve stimulation
system, in situ, in accordance with an embodiment;
FIG.6 is a functional block diagram depicting a paired-
VNSmotor therapy system including a manual VNSswitch,
in accordance with an embodiment;
FIG. 7 is a functional block diagram depicting an auto-
mated paired-VNS motor therapy system, in accordance
with an embodiment;
FIG. 8 is a screenshot of an initial interface screen, in
accordance with an embodiment;
FIG.9 is a screenshot of a therapy information screen, in
accordance with an embodiment;
FIG. 10 is a screenshot of a stimulation parameter input
screen, in accordance with an embodiment;
FIG. 11 is a screenshot of a therapy input screen, in
accordance with an embodiment;
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FIG. 12 is a screenshot of an IPG parameter input screen,
in accordance with an embodiment;
FIG. 13 is a screenshot of a therapy delivery screen, in
accordance with an embodiment;
FIG. 14 is a schematic diagram of an automated pairing
system, in accordance with an embodiment; and
FIG.15 is a screenshot of an automated therapy screen, in
accordance with an embodiment.
DETAILED DESCRIPTION
Tt should be understood at the outset that although an
illustrative implementation of one or more embodiments are
provided below, the disclosed systems and/or methods may
be implemented using any numberof techniques, whether
currently knownor in existence. The disclosure should in no
waybelimitedto the illustrative implementations, drawings,
and techniques illustrated below, including the exemplary
designs and implementations illustrated and described
herein, but may be modified within the scope of the
appendedclaims along with their full scope of equivalents.
The present application describes several embodiments, and
noneofthe statements below should be taken as limiting the
claims generally.
Where block diagrams have been used to illustrate the
embodiments, it should be recognized that the physical
location where described functions are performed are not
necessarily represented by the blocks. Part of a function may
be performed in one location while another part of the same
function is performed at a distinct location. Multiple func-
tions may be performedat the samelocation. In a functional
block diagram, a single line may represent a connection, in
general, or a communicable connection, particularly in the
presence of a double line, which may represent a power
connection. In either case, a connection may be tangible, as
in a wire, or radiated, as in near-field communication. An
arrow maytypically represent the direction of communica-
tion or power although should not be taken as limiting the
direction of connected flow.
Therapy
VNSis paired with a motor therapy by providing the
stimulation at some time during the motor therapy, for
example, the beginning of the motion. Becausethe cortical
plasticity is generated by the stimulation for a short time
period, as short as a few seconds, the VNS should be
provided so that most of the VNSis during the motions that
constitute the therapy.
With reference to FIG. 1, a flowchart 100 depicts a task
selection and therapy parameter selection process for a
paired-VNS motor therapy 100, in accordance with an
embodiment. The process 100 begins with a patient evalu-
ation at 102. The patient evaluation may include a standard
medical evaluation, medical history, and assessment of the
patient’s motordeficit. Persons of ordinary skill in the art are
aware of other information that can be included in a patient
evaluation. The patient’s motor deficit or handicap may be
assessed using standard motor deficit assessment criteria,
such as Fugl-Meyer, Barthel Index, Box and Block Test,
Canadian Occupation Performance Measure (COPM),
Functional Independence Measure (FIM), Motor Assess-
ment Scale (MAS), Action Research Arm Test (ARAT),
Modified Rankin Scale, Nine hole peg test, NIH Stroke
scale, Stroke Impact Scale (SIS) or any other appropriate
assessment measures.
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The process 100 may continue with setting the therapeutic
goals at 104. Therapeutic goals may include such things as
tying shoes, unlocking doors, eating, or performing other
basic life tasks. Persons of ordinary skill in the art are aware
of other types of goals.
Taking into consideration the therapeutic goals, a set of
tasks are selected at 106 that either address specific muscle
groups necessary to achieve the therapeutic goals, mimic the
basic life tasks, or mimic someportion of those tasks. For
example, if the goal is to be able to unlock a door, then the
task of inserting a key and tuning the key in a lock may be
selected as a task. On the other hand, if the patient is
suffering from moreserious disabilities in this regard, then
the task of reaching and grasping an object maybeselected,
as a first step toward the task of unlocking a door.
Tasks may include: Reach and grasp; Lift objects from
table; Circumduction and bimanual tasks (mainly involving
wrist and distal joints); Stacking objects; Slide credit card in
slot; Turning on and off light switch; Squeezing objects;
Writing; Typing; Stirring liquid in a bow] (bimanual); Dial
a cell phone (bimanual); Fold towels or clothes (bimanual);
Weara belt; Tying shoelaces; Eating; Brushing teeth; Comb-
ing hair.
Eachofthe tasks is defined with a spectrum oflevels. The
task of moving a weight, for example, may include smaller
weights and larger weights. Given a patient’s abilities and
the therapeutic goals, the initial task level is selected at 108.
The patient may begin performing the task at the selected
level. As the therapy proceeds, the level of the task may be
changedto reflect changes in the patient’s ability to perform
the task. If a patient becomes adept at performing a task at
the selected level, the level may be increased.If the patient
struggles to perform the task at a given level, the level may
be decreased.
Each task may be repeated many times. In a typical
therapy, a task may be repeated from about 30 to about 50
times in a session. The numberofrepetitions for each task
is selected at 110. The stimulation parameters for the vagus
nerve stimulation, such as the amplitude, pulse width, the
duration of the pulse train, frequency, and train period are
selected at 112.
With reference to FIG. 2, a setup and therapy delivery
process 200 is shown. The physical items necessary for a
selected task may be setup in the appropriate therapy space
at 202. The task and task parameters, such as what counts as
success, are explained to the patient at 204. The task delivery
software is used to control the delivery of stimulations and
to record data at 206. Whenthe patient is instructed that the
therapy has begun,the patient performsthefirst selected task
at 208, in accordance with the instructions given. At
approximately a determined point in the performanceofthe
task, the manual input device is used to cause the vagus
nerve of the patient to be stimulated at 210. Typically, the
vagus nerve is stimulated with a 500 millisecond pulse train
at approximately 0.8 milliamperes. The 500 millisecond
duration has been selected as sufficient to generate directed
plasticity. Experiments have shown that a 500 millisecond
stimulation generates directed plasticity that lasts less than 8
seconds. While longer pulse trains may be effective, the
shorter duration is typically preferred because the shorter
stimulation leads to less side effects. Following stimulation
at 212, there is a period of non-stimulation, which may beat
least as long as the preceding period of stimulation. The
period of non-stimulation may be a safety measure and may
be part of the therapeutic process. When the task has been
completed, the task level may be evaluated at 214, to
determine if the task level is too simple or too advanced for
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the patient. The task level may be changedat this point, as
appropriate. The patient then performsthe task again at 208
until the task has been repeated a predetermined number of
times.
With reference to FIG. 3, a setup and automated therapy
process 300 is shown. The physical items necessary for a
selected task may be setup in the appropriate therapy space
at 302. The setup may includeinitiating software to admin-
ister the automation. The task and the task parameters, such
as what counts as success, are explainedto the patient at 304.
The task delivery software is used to control the delivery of
stimulations and to record data at 306. When the patient is
instructed that the therapy has begun, the patient performs
the first selected task at 308, in accordance with the instruc-
tions given. A clinical control device detects task perfor-
mance at 310. Cameras or other sensors may be usedfor to
detect the patient’s movements. At a determined point in the
performanceofthe task, the control device causes the vagus
nerve of the patient to be stimulated at 312. Following
stimulation, there is a period of non-stimulation at 314,
which may be at least as long as the preceding period of
stimulation. The period of non-stimulation may be a safety
measure and maybepart of the therapeutic process. When
the task has been completed, the task level may be evaluated
at 316, to determine if the task level is too simple or too
advanced for the patient. The task level may be changed at
this point, as appropriate. The patient then performsthe task
again at 308 until the task has been repeated a predetermined
number of times.
With reference to FIG. 4, a graph depicts the timing of the
therapeutic task and examples of vagus nerve stimulation
timing. Before a motion begins, the patient forms a mental
intention and soon after, the motion begins. The task may
typically include a series of motions. For example, a task
may include, reaching, grasping, moving, releasing, and
returning. Between each of these motions is a transition
point or step that may be used to time the stimulation.
Finally, the motion ends.
The vagusnerve stimulation may beeffectively delivered
at various times during the therapeutic task. For example,
line a shows a vagus nerve stimulation given after the
intention to move is formed and before the motion begins.
Line b showsa vagus nerve stimulation delivered after the
motion begins. Line c shows a vagus nerve stimulation
delivered after a first transition point or step in the thera-
peutic task. Line d shows a vagus nerve stimulation deliv-
ered after a secondtransition point or step in the therapeutic
task. Line e shows a longer vagus nerve stimulation deliv-
ered between the time the motion starts and shortly after the
motion ends. The extended stimulation duration shown at
line e may be a single long pulse train or a series of
half-second pulse trains. Line f shows three vagus nerve
stimulations delivered during the therapeutic task, after the
motion begins, after the first step and after the secondstep.
Anyofthese VNS delivery methods maybe used singularly
or in combination.
Other systems may be used to monitor movements,so that
appropriate VNS timing can be determined. For a wrist
flexion, we might use a camera to model the movement as
a wire frame (e.g., bones with joints) and compare the
movement to past attempts and to optimal (e.g., normal)
movement in order to find the best movements that the
patient can generate. Movements, such as walking, grasping
or tying, may be quantified as location, direction, speed, and
angle of each joint as a function of time. For speech
production, vocalizations might be compared to previous
sounds and normal speech sounds produced by others. Vocal
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movements might be quantified based on the intensity,
duration, pitch, formant structure (vowels), formant transi-
tions (consonants), voice-onset time, and other standard
methods of quantifying speech sounds.
Selecting the appropriate paired VNS period depends on
the nature of the motion and the equipment used to provide
the pairing timing.
VNScould also be delivered during the planning stages
before movement begins. This usually takes only a few
hundred milliseconds but can be extended by giving a
sensory cue that instructs the subject what motion needs to
be done followed by a trigger cue some secondslatertelling
them whento begin the movement. This strategy makes it
possible to specifically pair VNS with motor planning,
which is an important part of motor control.
VNS maybe paired with the best movements in order to
shape future movements to be smooth and efficient (e.g.,
avoid spasticity, tremors, co-contraction of opposing
muscles, or the use of muscles that would not normally be
used to accomplish the task). VNS could also be delivered
after the movement is completed and determined to be
effective (e.g., the best movementof the attempts occurring
in the last about 30 seconds).
Thus, VNS could be delivered before, during, or after
movement. A measurement may show that the movement
will be, is, or was effective (e.g., acceptable or better than
average). Pairing may mean temporally associated with, not
necessarily simultaneous. Forthe rat study discussed below,
all VNS wasdelivered after the end of the target movement.
However, in many cases, the rats continue with the move-
ment after the target movement is achieved such that VNS
is sometime delivered while the rat is moving.
VNS may be paired with supervised, massed practice
movementtherapy three times per week. The duration of the
therapy may be six weeks. The duration of each therapy
session may be approximately one hour. The therapist may
determine each session’s therapy tasks to progress toward
the Canadian Occupational Performance Measure (COPM)
goals established at the intake evaluation. Goals may focus
on upper limb rehabilitation—most tasks may typically
require four movement components: reaching, grasping,
manipulating, and releasing an object. During each session
the ‘primary therapy principles’ may be used to guide the
developmentof the tasks to be performed each day. Prior to
each therapy visit, the therapist team may meet and develop
the task plan, ensure available materials and determine the
plan to increase and decrease difficulty to and determine a
realistic numberofrepetitions to be set as a goal.
The therapy implements several principles. The first prin-
ciple is task specificity. Improvement of a motor skill
requires practice of the movement; thus, each task may
include components of reach, grasp, manipulate, and release
specifically related to the target task.
Another therapy principle is that of repetition. Large
numbers of repetitions of each task is required to master a
motorskill, so the goal for therapy is to perform from about
30 to about 50 repetitions of a given task in a one-hour
session (about 120-about 200 total repetitions per session).
The focus of each therapy session may involve from about
3 to about 5 tasks in order to achieve the high numbers of
repetitions.
Anothertherapy principle is active engagement. Optimal
learning occurs with high levels of motivation and engage-
ment. Thus, participants may help to set goals, therapists
may make it clear how the target task relates to each goal,
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task practice may be varied to minimize boredom, and the
task may be constantly adapted to require active engagement
and effort to complete.
Another therapy principle is massed practice. Within a
session, massed practice promotes better learning than dis-
tributed practice. Thus, the therapeutic environment needs to
allow continuousrepetition. For example, therapist may line
up 10 objects in a row to allow for continuedrepetition. Rest
breaks are given only if requested by the patient or required
by the VNS.
Another therapy principle is variable practice. Variable
practice can be important for learning transfer. The move-
ment components may stay the same, and the context of the
components may change betweentrials or sessions.
The therapy session should consist of from about 3 to
about 5 tasks to allow variability and patient engagement. A
reach & grasp task may be included in each session. The
majority of patients need workin this area, so includingit as
a required task allows for consistency between patients and
useful in judging rehabilitation with assessments.
The therapy session may, at least initially, take place
under the supervision of one or more therapists. The patient
may perform the action without assistance from the thera-
pist. The therapist may manually deliver the VNS trigger
during the “key” part of the movementthat is being trained
(typically when the subject touches or is about to touch the
object during the reach). Alternatively, automatic delivery
could be used. Tasks may be appropriately graded to require
processing and effort by the patient but some degree of
success. As a general guideline, if the patient is unable to
complete the task successfully after approximately five
attempts, it should be downgradedin difficulty. This guide-
line may be superseded by the therapist’s clinical judgment
regarding the patient’s motivation,ability, and fatigue. If the
patient is able to complete the task with little difficulty
approximately (e.g., from about 10 to about 20 times) it
should be upgradedin difficulty. If they can completeit, but
it is slower than normal,then it is still a challenging task, and
variety may need to be introduced to alleviate boredom.
The upgrading and downgrading oftasks is dependent on
the patient’s goals as well as the effort required. The level of
strength and endurance required for the goal is also an
important consideration. For some patients, even higher
repetitions may be required to achieve the endurance needs.
The goal for repetitions of each task may be set ahead of
time by the therapist and communicated to the patient.
Grading of tasks can involve several different compo-
nents: Physical position of the patient. The patient may be
standing to introduce variety, add endurance, and add bal-
ance components to the task performance. Alternatively, the
patient maybesitting.
The position of the task materials may be changed. The
height of the task materials may be changed. The depth of
the task materials, placing the materials further away from
patient, may be changed. The degree from midline of objects
(left, midline, or right) may be varied. The weight of task
materials may be changed. The size of the objects may be
changed.
Adaptive equipment/materials may be used. A DYCEM
mat may be used to prevent an item from sliding. The
therapist may hold item to stabilize it. Materials may be used
to increase the grip of a small object to match ability (e.g.,
use foam to build up a pen to makeit easier to grasp).
The speed of task movement may be changed. A certain
numberof repetitions per minute may be implemented to
focus on the speed of movement. The patient may be
encouraged to slow down task performance.
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The stability of the object may be changed. The object to
grasp may be stable. The object to grasp may be moving
(e.g., a ball is rolling on a table). The object may be placed
on slippery surface or a sticky surface.
The same task can be practiced with different forms of
material to achieve variety but still maintain high levels of
repetition ofthe overall task. For example, to work on grasp
and release of small objects, a plethora of everyday objects
could be used, such as coins, paperclips, credit cards, cell
phones, etc.
Task performance may be monitored by the therapist, and
each VNSstimulation may be recorded by the software and
presented to the therapist as a visual counter on the screen.
If in the therapist’s assessment there are other rehabilita-
tion issues that may require intervention, such as restricted
range of motion, this can be addressed outside of the about
one hour motorpractice or addressedpriorto the start of the
VNS therapy. If there are significant non-motor impair-
ments, such may disqualify the participant.
Patients may not be given a home exercise program of
specific items to practice. However, they may be told to
participate in their normal every day activities and be
encouraged to “practice using your impaired upper extrem-
ity as much aspossible”.
Examples of Goal and Task Grading
Example 1
Grasp and Release
The patient’s goal is to be able to unload dishwasher. The
target task involves the ability to grasp, manipulate, and
release a variety of objects along with a variety of strength
and range of motion requirements and some degree of
endurance(e.g., being able to stand for the entire duration).
Materials: spoon, fork, knife, large serving spoon, large
and medium mixing bowl, coffee mug, drinking glass, small
plate, large dinner plate, a DYCEM mat, foam.
Method:First, Patient sits at table with objects at midline
Second, for each task repetition, the patient reaches out to
grasp object and place on shelf about six feet abovethe table.
Third, 10 objects are lined up to allow continuousrepetition
of the movement and achieve high numbers.
Grading: The task can be upgraded in difficulty by:
challenging patient that a certain number of repetitions be
completed in one minute; using a variety of sizes instead of
the same size/shape in a row; requiring the patient stand to
perform; requiring the patient bend down to retrieve the
object; requiring the patient reach higherto place the object;
requiring the patient sort and place each object in the correct
position in a drawer; mixingbilateral lifting with single hand
tasks; silverware is placed in a basket to be removed from;
weight baring is required in one limb to stabilize during a
task (e.g., the patient leans on his less affected arm and
practices wiping the table with the impaired arm); and/or
including bilateral tasks that aren’t symmetrical (e.g., the
patient uses a spray bottle with the impaired hand andcleans
with the less affected arm).
The tasks can be downgraded in difficulty by: wrapping
the object in foam to makeit easier to grasp; placing objects
ona DYCEM mat to minimize slipping; requiring object be
moved from impaired hemifield to less impaired hemifield;
and/or performing bilateral tasks.
Introducing variety and still achieving high numbers of
repetitions. First, the goal for this task is 200+ repetitions.
Since the goal is a complex task that involves several
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components this may be the only task performed is this
session. Second,for the first part of the session, the task may
be designed to primarily challenge the grasp. The individual
maygrasp objects in a variety of challenging ways with less
challenge focused on the reach or manipulate aspect of the
entire task, for 100 repetitions (e.g., 10 objectsx10 repeti-
tions) This may take about 25 minutes. There is a line of
objects set up, thus there may be very little rest between
repetitions. The second part may have greater emphasis on
the reach part of the task, but the task is still repeating the
components. The individual may now pick up arelatively
easy object, that is further away from him, requiring a reach
to different aspects ofthe field in front of him. Each of these
trials may take longer. He may perform 35 trials ofthis from
a variety of reach locations, which may require approxi-
mately 15 minutes. For variety, the object could be close and
the he would be required to reach at the limits of his ability
for the release of the object. Finally, the third part may focus
on manipulation and precision. For these trials, the initial
grasp and reach is not as difficult, but the manipulation/
release may be repeated, e.g. about 75 times in about 20
minutes. This may require precise placement of an object
(e.g., the participant has to stack a set of spoons on top of
each otheror place cups in a precise stack. The day’s session
was focused on the goal with all repetitions were focused
specifically toward the sametask, but different aspects of the
goal were emphasized to eliminate boredom and fatigue.
Example 2
Handwriting
Thepatient’s goal involves being able to write checks and
thank you notes.
Materials: pen, paper, pencil, dry erase board, cylindrical
foam, sand tray, shaving cream, andtray.
Method: First, the patient sits at a table with a tray with
a mound of shaving cream. Second, the patient practices
spreading the cream evenly throughout the tray. Third, the
patient practices free writing with a finger or with a stylus.
Fourth, the patient practices loop drawing or free writing
with writing utensil of choice. Fifth, the patient practices
filling out forms or line writing within constrained box.
Grading: The tasks can be upgraded in difficulty by:
increasing the numberofwords written (e.g., phone number,
address, sentences); decreasing task difficulty by using built
up writing utensils to aid in grip; and/or decreasing task
difficulty by using dry erase board, shaving cream, writing
large letters or loops.
Example 3
Bilateral Activity
The patient’s goal involves folding laundry.
Materials: 10 wash cloths, 10 hand towels, 10 bath towels,
10 t-shirts, 10 pairs of socks.
Method: First, the patient may sit or stand at the table.
Second, the patient may fold towels at midline. Third, all
towels may be folded in half and then in half again using
bilateral upper extremities. Fourth, folded towels may be
placed in laundry basket.
Grading: Tasks may be decreasedor increasedin difficulty
by changing the size and weight of objects. Tasks may be
decreased or increased in difficulty by changing the number
of folds required in the object. Task can be increased or
decreased in difficulty by changing the location of where the
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object is to be grasped or placed. The therapist may unfold
the towels to allow rapid repeat of task.
Example 4
Fine Motor Tasks
The patient’s goal involves fishing.
Materials: 10 fishing lures, various sized bobbers, fishing
weights, fishing line, a tackle box, and a fishing reel.
Method: First, The tackle box is placed at the patient’s
midline. Second, fishing weights bombers and lures are
placed on the affected side. Third, the patient is instructed to
pick up items and place them in the top box. Fourth, the
patient is instructed to pick up items oneat a time.Fifth, the
patient practice is tying a fishing line. Sixth, the patient
practices stabilizing the fishing rod with one hand and
reeling with the other hand.
Grading: Increase or decrease task difficulty by increasing
or decreasing the size of the items in the tackle box. Increase
or decrease the difficulty by increasing or decreasing the
weight of items at the end of the fishing line.
Example 5
A Discrete, Specific Task
The patient’s goal involves opening doors.
Materials: A set of experimental doors knobs with various
types of locks, keys, and actual doors.
Method: First, the key is built up with foam or putty to
allow easier grasp of the key. Second, the knobs/locks are
placed at an easily accessible height to allow the patient to
sit and perform the task. Third, actual doors are used and the
patient has to fully open the door and walk through.
Grading: A variety of knob types are used requiring
different aspects of grasp. The knobs/locks are placed at
progressively more difficult positions. The actual doors are
light or heavy.
Systems and Devices
With reference to FIG. 5, an implantable vagus nerve
stimulation system 500 is shown in situ. The implantable
vagus nerve stimulation system 500 includes an IPG 506,
electrodes 502, and a lead 504 connecting the IPG 506 to the
electrodes 502. The IPG 506 maybe implanted in the chest
of a patient 512. The lead 504 travels below the skin to the
neck of the patient 512. The electrodes 502 may be of the
cuff-electrode type and may be attached to the left vagus
nerve 508 in the neck of the patient 512. The IPG 506 sends
electrical stimulation pulses through the lead 504 to the
electrodes 502, causing stimulation of the vagus nerve 508.
The IPG 506, lead 504, and electrodes 502 function simi-
larly to the implantable vagus nerve stimulation systems
commonly usedin the treatment of epilepsy and as described
in the parent patent application to this application.
Vagus nerve stimulation maybe delivered with electrodes
placed in direct contact (or proximate to) the left cervical
vagus nerve, in the patient’s neck. Other forms of stimula-
tion may be used, including transcutaneous electrical or
magnetic stimulation, physical stimulation, or any other
form of stimulation. An example of a transcutaneous elec-
trical stimulation system that could be adapted for use in the
described therapy may be found in U.S. Pat. No. 7,797,042.
Stimulation of the vagus nerve may be doneat othersites
along the vagus nerve and branches of the vagus nerve.
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With reference to FIG. 6, a stroke therapy system 600 is
shown. The implanted stimulation system 500 communi-
cates wirelessly with an external communication device 602.
The external communication device is coupled to a clinical
controller 604. The clinical controller 604 may be a com-
puter, such as a laptop computer, running specialized paired
VNSstroke therapy software. A manual input device 606
may be coupled to the clinical controller 604. The manual
input device 606 may be a hand switch, a foot switch, a
mouse button, or a keyboard key. When the manual input
device 606 is switchedor pressed, the clinical controller 604
sends a signal to the external communication device 602.
The external communication device 602 sendsa signalto the
implanted stimulation system 500. The implanted stimula-
tion system 500 receives the signal at the IPG 506 and
generates stimulation of the vagus nerve at the electrodes
502.
With reference to FIG. 7, a stroke therapy system 700 is
shown. The implanted stimulation system 500 communi-
cates wirelessly with an external communication device 602.
The external communication device is coupled to theclinical
controller 604, which may be coupled to manual input
device 606. A camera 608 and sensor 610 may also be
coupled to the clinical controller 604. The camera 608
and/or sensor 610 detect motion or attributes of the motion.
The data detected by the camera 608 and/or sensor 610 are
processed by the clinical controller 604. When the data
indicates a threshold has been reached during the perfor-
mance of the therapeutic task, the clinical controller 604
may senda signalto the external communication device 602,
and the external communication device 602 may send a
signal to the implanted stimulation system 500. The
implanted stimulation system 500 receives the signal at the
IPG and generates stimulation of the vagus nerve at the
electrodes. The manual input device 606 may be used to
control the delay between stimulations.
The system may also implement magnet mode, where a
hand-held magnet may be swiped over the IPG in order to
cause a stimulation. The specialized stroke software may
include a magnet modesetting, to provide for use of this
mode. When in magnet mode, swiping the hand-held magnet
will deliver a pre-programmedstimulation (i.e. at whatever
settings were programmed). The reasonforthis feature is the
physician and patient do not need to be in proximity of the
computer/external controller, an arrangement that may work
better for some kinds of tasks. When not in magnet mode the
magnet causes stimulation to stop, as a safety feature.
The clinical controller 604 may run specialized stroke
therapy software. The specialized stroke therapy software
manages patient data, controls the stimulations, sets the
stimulation parameters, and records data from the therapy.
FIGS. 8-13 show screenshots from an embodiment of the
stroke therapy software. With reference to FIG. 8, a screen
shot showsan initial page of the specialized stroke therapy
software. Theinitial page allowsthe user to navigate to input
screens for programmingthe implant, set the therapy param-
eters, and access patient data. With reference to FIG. 9, a
screen shot depicts the input screen for programming the
implantable system. With reference to FIG. 10, a screen shot
depicts an input screen for further programming the implant-
able system. With reference to FIG. 11, a screen shot depicts
an input screen for advancedsettings. With reference to FIG.
12, a screen shot depicts an input screen for implantable
parameters. With reference to FIG. 13, a screen shot depicts
a therapy delivery screen. On the therapy delivery screen, a
therapeutic task may beselected.
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With reference to FIG. 14, an automated stimulation
pairing system 800 is shown. One or more objects 802 such
as a cylinder, a key, a block, or any other object suitable for
manipulation-type tasks is placed in a workspace. Portions
of the patient’s body, such as a hand orfingers, may also
serve as objects. The object 802 is marked with a colored
marker 804 such as a piece of colored tape, a spot of paint,
a colored sticker or any appropriate manner of marking an
object with color. For some tasks, such as rotation, the
colored marker 804 needs a long edge and a short edge, as
shown. Any object 802 can be marked with a sticker or
tracking sphere and tracked for the therapy. A camera 608 or
a plurality of cameras 608 are placed around the workspace
so that the object 802 and the marker 804 is within view of
the camera 608. Cameras 608 may also be used to monitor
the patient rather than an object or marker. In accordance
with an embodiment, a camera may be placed above the
workspace. The cameras 608 are connected to the clinical
controller 604. Specialized software running on the clinical
controller 604 uses data from the cameras 608 to determine
the relative position, velocity, rotation or any other metric
related to the performance of the given task. The clinical
controller 604 uses the determined metric to decide when
stimulation is appropriate and sends a stimulation signal to
the external communication device 602. A manualinterrupt
606 may be implementedso that a therapist can interrupt and
control the rate of stimulation. The automated system 800
may be completely automated, in a closed loop setup so that
the next stimulation is automatic. The automated system 800
may be arranged in an open loop fashion, so that the
therapist must intercede before the next stimulation.
The specialized software monitors x, y, z translations of
objects with an attached target. The specialized software
includes parameters for a variety of tasks that may be
performed using this type of closed loop automated system.
Using a single camera and colored markers, a wide variety
of tasks can be automated. Motion, speed, height, initiation
of translation, acceleration, angular rotation, angular veloc-
ity, angular acceleration, force, velocity, acceleration, angu-
lar acceleration, path length, time to target, distance traveled
to target, range of motion, height of object and combinations
of these and other metrics can be usedto trigger stimulation.
Some example tasks include: slide a cup, lift a cup, spin a
cup, Lift a cup and moveit to some other location, move an
object by rotating your wrist, turn a key, flip a coin, pick up
a spoon. Tasks may be combinations ofmovementsortasks,
such aslifting a cup and bring it to the mouth,lifting a penny
and putting it on a shelf, lifting a key, putting it in a lock and
turning the key,or sliding a cup to some point, picking it up,
and spinning it 30 degrees. The tasks may be designed to
isolate movements of specific muscle groups. Adaptive
tracking of a base metric, based on past performance within
a session or between sessions, can be used to generate
improvement.
The automated paired stimulation system may be
arranged so that when the object 802 is movedinto or out of
a pre-defined boundary that surrounds the object, vagus
nerve stimulation is triggered.
A marker 804 can be placed on the patient’s hand or arm
rather than on an object.
Whenthe object 802 when lifted or lowered in the z-axes
i.e. towards the camera 608, the change in the area of the
marker 804 may be detected and used totrigger stimulation.
The object 802 may be movedto specified places on the
surface. For example, the task may require the patient to
US 9,522,272 B2
15
movethe task object 802 to a square on the surface. When
the object is successfully moved to the square, the VNS
stimulation is triggered.
Stimulation is triggered during the movements. The spe-
cialized software may stimulate on the best trials, such as
shortest path length, fastest movement, optimal acceleration,
minimal jitter, maximum height and other metrics, to pro-
vide pairing with improved performance.
The manualinterrupt 606 may be adapted to require the
therapist after a stimulation from the automatic software to
press the manualinterrupt 606 to indicate a new stimulation
can be permitted. This allows the physician or patient to
reset the object 802 or for the physician to demonstrate the
movement without accidentally causing a stimulation.
In accordance with another embodiment, EMG (muscle
electrical activity) may be measured and used to trigger
paired vagus nerve stimulation.It is also possible to quantify
or image specific movements of the patient such as a
patient’s walking gait, eye position or tongue position and
pair them with VNS. Muscle activity in muscle groups that
are only partly under voluntary control (e.g. bladder and
sphincter) may be usedto trigger paired vagus nerve stimu-
lation.
The automated system may support such tasks as: Reach
and grasp; Reach and grasp (small/large objects) (gross and
fine movements, dexterity); Point and/or press objects with
finger (accuracy); Insert small objects into wells of different
sizes (accuracy); Flip cards or sheets of paper (Circumduc-
tion and dexterity); Lift objects from table; Circumduction
and bimanual tasks (mainly involving wrist and distal
joints); Lock and key (Circumduction); Turning a doorknob
(Circumduction); Open and close a pill bottle (bimanual;
flexion extension wrist); Pour water from a pitcher to glass
(bimanual).
Motion can be detected using a camera or other detection
devices. The system may operate by detecting change in
color of the object by a camera, breaking an IR beam PIR
motion sensor, engaging a force transducer, turning a knob
or dial potentiometer, pressing a button, flipping a switch,
activating a motion sensor, activating a piezoelectric sensor,
ultrasonic sensors for detecting distance, or any other appro-
priate measure of motion.
The automated system may be designed to do is to
determine a “good”trial and only stimulate on a goodtrial.
A goodtrial may be determined by comparingthe history of
past movements, running an appropriate algorithm on a
clinically relevant parameter(s) and using this determination
to trigger stimulation. Good could be defined ahead of time
by speed, acceleration, strength, range ofmotion, like degree
of wrist turn, or any other appropriate defining quality.
Similar automated systemsare described in U.S. Pat. Nos.
6,155,971 and 7,024,398.
With reference to FIG. 15, a screenshot of a specialized
automated pairing software is depicted. Patient data and
motion parameters may be entered or selected. A camera
view detects the motion of an object and provides vagus
nerve stimulation, in accordance with the selected param-
eters.
Support
Although sensory and motor systems support different
functions, both systems can exhibit topographic reorganiza-
tion of the cortex following training or injury. Tone training
(conditioning orartificial stimulation) can increase the rep-
resentation of the tone in the auditory cortex. Operant
training on a tactile discrimination task increased soma-
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tosensory cortical representation of the digit used in training.
Similar changes can occur in the motor cortex following
training with precise digit movements. Motivation andfre-
quency of training influence the degree of cortical map
plasticity. Deprivation caused by peripheral injury changes
the organization of sensory and motorcortices. For example,
digit amputation or nerve transection causes receptive fields
in the inactivated somatosensory cortex to shift to neigh-
boring digits. Likewise, transecting the facial nerve reduces
the number of motor cortex neurons that elicit vibrissae
movements while increasing the numbereliciting forelimb
movements. Targeted lesions to the sensory or motor cortex
can cause the surrounding healthy cortical areas to take on
some of the damaged area’s lost functionality. Drugs that
block reorganization of cortical representations in the sen-
sory cortex can also block reorganization in the motor
cortex. Collectively, these results suggest that the mecha-
nisms regulating cortical plasticity are common to both
sensory and motorcortices.
The vagus nerve maysend afferents to a numberofnuclei
knownto release neuromodulators associated with cortical
plasticity, including the locus coreleus, raphe nuclei, and the
basal forebrain. The vagus nerve has several efferents to
major organs in the body, including the heart; however, a
large portion of the vagus nerve consists of afferent connec-
tions to several targets in the midbrain. Low-current stimu-
lation of the left vagus nerve is a commonly used treatment
for drug-resistant epilepsy that is associated with minimal
risks. Complications associated with stimulation to the heart
are avoided due to the limited contributionsofthe left vagus
nerve to cardiac activity and the minimal levels of current.
Unilateral stimulation of the vagus nerve can result in
bilateral activation of the nucleusof the solitary tract and its
projections to the locus coeruleus and raphe nucleus. Acti-
vation of the locus coeruleus can lead to activation of the
nucleus basalis through a1 adrenoreceptors. Although the
exact mechanismsof action are not entirely yet understood,
VNShas demonstrated several beneficial effects for major
depression, mood enhancement, improved memory, deci-
sion making, and improved cognitive abilities in Alzheim-
er’s patients, and it reduces edema following brain trauma.
Dueto the knownrelease of multiple neuromodulators, VNS
has recently become an object of study in regulating cortical
plasticity.
Pairing VNS with motor therapies can be accomplished
using several types of pairing systems. A timing control
device can initiate or provide the therapy and the VNSat
appropriate times. A timing control device can monitor the
therapy and provide VNS at appropriate times during the
therapy. A timing control device can receive manual inputs
from a patient or clinician during the therapy and generate
VNSat appropriate times.
Several experiments have been performed that demon-
strate the effectiveness of pairing motor therapy with VNS.
The methodsandresults of those experiments are described
below.
The wheel spin task required the rat to spin a textured
wheel towards themselves. Rats used movements of the
wrist and digits to complete this task. Stimulation and
reward occurred after the rat spun the wheel about 145°
within about one second period. The lever press task
required the rat to depress a spring-loadedlever twice within
about 0.5 seconds. The range ofmotion required to complete
this task pivoted primarily around the shoulder joint. Stimu-
lation and reward occurred after the second lever press.
Although sensory and motor systems support different
functions, both systems exhibit dependentcortical plasticity
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under similar conditions. If mechanisms regulating cortical
plasticity are common to sensory and motor cortices, then
methods generating plasticity in sensory cortex should be
effective in motor cortex. Repeatedly pairing a tone with a
brief period of VNS increases the proportion of primary
auditory cortex responding to the paired tone. It was pre-
dicted that repeatedly pairing VNS with a specific move-
ment would result in an increased representation of that
movement in primary motor cortex. As such, VNS was
paired with movements of the distal or proximate forelimb
in two groups ofrats. After about five days of VNS move-
ment pairing, intracranial microstimulation was used to
quantify the organization of primary motor cortex. Larger
cortical areas were associated with movements paired with
VNS.Rats receiving identical motor training without VNS
pairing did not exhibit motor cortex map plasticity. These
results suggest that pairing VNS with specific events may act
as a general methodfor increasing cortical representations of
those events. VNS-movementpairing could provide a new
approach for treating disorders associated with abnormal
movementrepresentations.
Repeatedly pairing VNS with a tone may cause a greater
representation of that tone in primary auditory cortex. This
map expansion is specific to tones presented within a few
hundred milliseconds of VNS. No previous study has
reported the effects of pairing VNS with a specific move-
ment on cortical plasticity. If the mechanisms regulating
map plasticity in the auditory cortex are the same in the
motor cortex, then VNS-paired with a movement should
generate mapplasticity specific to the paired movement. In
one embodiment, VNS waspaired with a specific movement
to test if this method could be used to direct specific and
long-lasting plasticity in the motor cortex.
In one embodiment, thirty-three rats were randomly
assigned to receive a vagus nerve cuff electrode or a non-
functional, sham vagus nerve cuff electrode. After recovery
from the surgery implanting the nerve cuff, thirty-one rats
were trained to perform one of two operant motor tasks
using either their proximal or distal forelimb. After the rats
learned to reliably generate the required movement, VNS
was paired with the movement several hundred times each
day for about five days. For twenty-five of these rats,
intracranial microstimulation (ICMS) was used to quantify
the reorganization in the primary motor cortex about 24
hoursafter the last training session. Instead of ICMS,six of
the non-stimulated rats received ischemic motor cortex
damage and were retested to confirm that accurate perfor-
manceofthe task requires motor cortex. Motor cortex ICMS
was performed on two rats that had functional VNSelec-
trodes and received the same amount of VNSbut received
no motortraining. An additional group of eight experimen-
tally naive rats that had not received motortraining or VNS
also underwent motor cortex ICMS.
Acomparison of the motor maps from the rats with sham
cuffs to the rats with functional cuffs allows a determination
as to whether pairing VNS with the movements enhances
cortical plasticity. Comparison of the motor maps from rats
that were performing a task during VNS with rats that were
not performing a task during VNSallows a determination as
to whether the motor task was required to generate motor
cortex plasticity.
Forty-one adult, female Sprague-Dawley rats were used
in this experiment. The rats were housed in a 12:12 hour
reversed light cycle environment to increase their daytime
activity levels. During training, the rats’ weights were
maintained at or above 85% of their normal body weight by
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restricting food access to that which they could obtain
during training sessions and supplementing with rat chow
afterward when necessary.
Rats were implanted with a custom-built cuff electrode
prior to training. Stimulating cuff electrodes were con-
structed as previously described. In one embodiment, two
TEFLON-coated multi-stranded platinum iridium wires
were coupled to a section of Micro-Renethane tubing. The
wires were spaced about two mm apart along the length of
the tubing. A region of the wires lining the inside circum-
ference of the tube about eight mm long wasstripped of the
insulation. A cut was made lengthwise along the tubing to
allow the cuff to be wrapped around the nerve and then
closed with silk threads. This configuration resulted in the
exposed wires being wrapped around the vagus nerve at
points separated by about two mm, while the leads exiting
the cuff remained insulated. These insulated wires were
tunneled subcutaneously to the top of the skull and attached
to an external connector. A second group of randomly
chosen rats received similar cuffs, but with silk threads in
place of the platinum iridium wires.
In one embodiment,all the steps of the surgeries were the
same regardless of the type of cuff implanted. Rats were
anesthetized using ketamine hydrochloride and xylazine
with supplemental doses provided as needed. After rats were
no longer responsive to toe pinch, incision sites atop the
head and along the left side of the neck were shaved and
cleaned with betadine and about 70% isopropyl]alcohol. The
application of opthomalic ointment to the eyes prevented
corneal drying during the procedure and a heating pad
maintained the rats’ body temperature at about 37° Celsius
(C). Doses of cefotaxime sodium and a dextrose/Ringer’s
solution were given to the rats before and during the surgery
to prevent infection and provide nourishment throughout the
surgery and recovery. Bupivicaine injected into the scalp and
neck further ensured that the rats felt no discomfort during
surgical procedures. An initial incision and blunt dissection
of the scalp exposed the lambda landmark on the skull. Four
to five bone screws were manually drilled into the skull at
points close to the lambdoid suture and over the cerebellum.
After an acrylic mount holding a two-channel connector was
attached to the anchor screws, an incision and blunt dissec-
tion of the muscles in the neck exposed the left cervical
branch of the vagus nerve. As in humans,only the left vagus
nerve was stimulated because the right vagus nerve contains
efferents that stimulate the sinoatrial node and can cause
cardiac complication.
In one embodiment, eighteen rats received the platinum
iridium bipolar cuff-electrodes while another thirteen
received the sham cuffs in which silk thread replaced the
platinum iridium wires. Leads (or silk threads) were tun-
neled subcutaneously and attached to the two-channel con-
nector atop the skull. All incisions were sutured and the
exposed two-channel connector encapsulated in acrylic. A
topical antibiotic cream was applied to both incision sites.
After surgery, the rats with silken threads looked identical to
the rats with wired cuffs after the surgeries. Rats were
provided with amoxicillin (about 5 mg) and carprofen (about
one mg)in tablet form for three days following the surgeries
and were given one week of recovery before training began.
During the week of recovery, rats were habituated to having
the stimulator cable coupled to the two-channel connector
on their heads. This method of cuff electrode construction,
implantation, and stimulation delivery has repeatedly been
shown to consistently result in VNS that persists over the
full-term of the experiment.
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In one experiment, rats were trained on either the wheel
spin task (n=10 rats) or the lever press task (n=21 rats).
Training occurred in two daily sessions for five days each
week. Both tasks involved quick movementof the forelimb
in order to receive a sugar pellet reward. Rats initiated each
trial, but a delay of at least two seconds was required
between trials to allow the rats to eat the sugar pellet. The
wheel spin task required the use of muscles located primar-
ily in the distal forelimb, especially the wrist, while the lever
press task required the use of the shoulder and the proximal
forelimb.
The initial shaping procedures were similar for both
motortasks. In one embodiment, rats were placed in a cage
and allowedto freely explore the area. A tether was coupled
to the rats’ heads to familiarize the animals with the feeling
of the connection. Each time the rats approached the
response device(e.g., the lever or wheel), they received a 45
mg sugar pellet dispensed into a pellet dish located within
the cage. Restrictions were gradually placed on rewarding
the rats’ proximity to the response device until the rats had
to be next to, and then touching, and finally using the device
to receive the reward. An experimenter conducted shaping
procedures manually. Rats typically took four 30-minute
sessions to become familiarized to the response device.
After shaping, all training sessions were automated using
custom-written programs.
In one embodiment, rats that trained on the wheel spin
task were required to spin a textured wheel below the floor
of the training cage to receive a sugar pellet reward. Trials
were initiated by the rats, but rewards were spaced at least
two secondsapart by the computer program. In one embodi-
ment, rats were initially rewarded for spinning the wheel
about 3° within a one-second period when each new stage
began. After about 35 successful spins of the wheel, the
degree of rotation required for a reward increased to about
30°, then about 75°, and finally about 145°. After about 35
rewards at the highest rotational requirement, the rats
advanced to the next stage of training (e.g., more restricted
access to the wheel) where they repeated all of the levels of
increasing rotation again as previously described. Rats dem-
onstrated a paw preferenceearly in training and continued to
use that paw for the remainder of the sessions.
In one embodiment,rats depressed a leverinitially located
inside the training cage to receive a sugar pellet reward. The
training cage was a wire cage with dimensions of approxi-
mately 20 centimeter (cm)x20 cmx20 cm with a Plexiglas
wall opposite the door. In one embodiment, all training
sessions other than the shaping sessions were aboutfifteen
minutes long and occurred about twice daily. Trials were
initiated by the rats, but rewards were only given to trials
occurring at least five seconds apart. After receiving about
60 pellets in about two shaping sessions by pressing the
lever, the rats learned to press the lever twice in an about
three-second period for the same reward. The interval
between lever presses that elicited a reward was reduced
from about three seconds to about two seconds, then about
one second, and finally about 500 milliseconds (ms), with
about 15 successful trials as the criterion for advancing.
After successfully pressing the lever twice within about 500
ms about forty-five times, the lever was gradually with-
drawn out of the cage. The lever wasinitially located about
four cm inside the cage, then moved to about two cm inside
the cage, and then to about 0.5 cm, about 1.5 cm, and about
2.0 cm outside of the cage. The criterion for retracting the
lever was about 15 successful double-lever presses for each
position, except for about 0.5 cm outside the cage, which
required 30 successful trials. In one embodiment, rats
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reached through a window in the Plexiglas wall that was
about one cmxabout seven cm to reach the lever outside the
cage. The edge of the window waslocated about two cm
from the cage wall, while the lever was offset so that the
middle of the lever lined up with the edge of the window
furthest from the wall. This arrangementrestricted the rats
so that they could only comfortably press the lever with their
right paw. This aspect of the task design was important for
confirming the importance of the motor cortex for the lever
press task with motor cortex lesions.
To confirm that accurate performance on the lever press
task requires motor cortex, six rats implanted with the nerve
cuffs and trained on the lever-press task without stimulation
received motor cortex lesions and were retested for about
two days following about one week of recovery. Based on
procedures by Fang et al., (2010), the vasoconstrictor
endothelin-1 was used to selectively lesion the caudal fore-
limb area of the motor cortex. Basic surgical procedures for
cleaning, anesthesia, and post-surgical care were the same as
the cuff implantation surgery. After cleaning the top of the
head, an incision was made longitudinally and a craniotomy
was performed over the primary motor cortex caudal fore-
limb area contralateral to the trained forelimb (about 2.75
mm to about -0.75 mm anteroposterior and about 2.25 mm
to about 3.75 mm mediolateral, relative to bregma).
Endothelin-1 (about 0.33 microliters (uL) of about 0.3
micrograms(ug) mixed in about 0.1 uwL saline) was injected
at a depth of about 1.8 mm using a tapered Hamilton syringe
along a grid within the craniotomy at about 2.5 mm, about
1.5 mm, about 0.5 mm, and about -0.5 mm anteroposterio-
rally, and about 2.5 mm and about 3.5 mm mediolaterally
relative to bregmafor a total of eight sites according to one
embodiment. KwikCast silicone gel was used to replace the
removed skullcap and the skin was sutured. The lever press
task was the only task tested with motor cortex lesions due
to the ease with which the forelimb used in the task could be
restricted. The lever press task could not be completed with
the left forelimb because of the cage design. Lesions were
made in the left motor cortex forcing therat to try to use its
impairedright forelimb to complete the task. Impairments to
the distal forelimb accompany impairments to the proximal
following motor system lesions. Additionally, the lesion size
covers the entire caudal forelimb area; therefore, it is
expected that impairmentsto the lever press task would also
indicate impairments to the wheel spin task.
Duringthe final stage of the motortasks, reaching through
a window about 1.2 cm wide and spinning the wheel about
145° within about one second period or pressing the lever
located about two cm outside the cage twice within about
500 mstriggered a food reward and VNS.Stimulations were
delivered approximately 75 msafter the wheel reached 145°
or the lever triggered the second press. Rats typically
continued to spin the wheel or press the lever beyond the
required criterion, such that the movements werestill occur-
ring during VNS. In one embodiment, VNS was always
delivered as a train of about 15 pulses at about 30 hertz (Hz).
Each about 0.8 milliamps (mA) biphasic pulse was about
100 microseconds (1s) in duration. The train of pulses was
about 500 ms in duration. Previous studies have demon-
strated that the amplitude of electroencephalographic mea-
sures may be reduced and neuronal desynchrony may
increase during VNSusing the described electrode implan-
tation, which may indicate a successful stimulation of the
vagus nerve. VNS-movementpairing during the final stage
of training continued for one week (in one embodiment,
10xabout 30 minute sessions for the wheel-spin task and
10xabout 15 minute sessions for the lever-press task), deliv-
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ering around 1,200 total stimulations. Previous research has
shownthat this form ofVNS doesnotalter heart rate, blood
oxygenation level, or ongoing behavior, suggesting that the
stimulation is neither aversive nor rewarding to the animals.
In one embodiment, connections and stimulations from
the external stimulator to the rats were identical betweenrats
implanted with functional or sham VNSelectrode cuffs. The
sham cuffs with silk threads in place of platinum iridium
leads did not carry an electrical charge when stimulated.
This difference in the cuffs allows experimenters to remain
blind during training to stimulated and sham rats.
The day after the last training session ofVNS movement
pairing, the organization of primary motor cortex contralat-
eral to the trained paw was defined using standard ICMS
mapping procedures. In one embodiment, an additional eight
rats that did not train or receive VNSalso underwent ICMS
procedures to the left cortex to compare the effects of
training on motor cortex organization. After placing the rat
in a stereotaxic frame with a digital readout, a craniotomy
was performed to expose the motor cortex. In one embodi-
ment, parylene-coated tungsten electrodes were inserted to a
depth of about 1,800 micrometers. Stimulation occurred
following a grid with about 500 um spacing. Sequential
electrode placements were made at least one mm apart
wherepossible. ICMS wasdelivered once per second. In one
embodiment, each stimulation consisted of an about 40 ms
pulse train of about ten 200 us monophasic cathodal pulses
delivered at about 286 Hz. Stimulation intensity was gradu-
ally increased (from about 20 to about 200 microamperes
(uwA)) until a movement was observed. If no movement was
observed at the maximal stimulation, then the site was
deemed nonresponsive. The borders ofprimary motor cortex
were defined based on unresponsive sites and stopped at the
posterior-lateral vibrissae area, which is known to overlap
the somatosensory cortex.
In one embodiment, motor mapping procedures were
conducted with two experimenters, both blind to the experi-
mental condition of the rat. The first experimenter placed the
electrode and recorded the data for each site. Because the
motor cortex is organized with similar movements often
occurring in the general vicinity of each other, the second
experimenter was kept blind to the electrode placement to
avoid potential biasing. The second experimenter delivered
stimulations while observing which parts of the body moved
in response. Movements wereclassified based on the part of
the body that moved using the threshold stimulation current.
Larger movements were obtained using higher current
stimulations and were used when necessary to disambiguate
movements too small to confidently classify at threshold
levels. The first stimulation site was placed in an area often
resulting in movement of the lower forelimb. Subsequent
stimulation sites were randomly chosen and did not extend
beyondestablished border(e.g., unresponsive) sites. Move-
ments of the vibrissae, face, eye, and neck were classified as
“head”. Movements of the shoulder, elbow, and upper fore-
limb, e.g., proximal forelimb, were classified as “upper
forelimb”. Movements of the wrist and digits were called
“distal forelimb”. “Hindlimb”included any movementin the
hindlimb of the rat. Cortical area was calculated by multi-
plying the numberofsites eliciting a response by about 0.25
mm. Four sites equal about one mm”.
To confirm that VNSalone does not produce motor cortex
map reorganization, two rats that were never trained to
perform a motor task were placed into a training cage and
received randomly delivered VNS (e.g., not paired to a
specific movement). Except for the movementpairing, VNS
in this group was identical to the groups above. In one
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embodiment, each animal waspassively stimulated for two
30-minute sessions per day with an about two-hour break
between sessions, and repeated for about five days. Within
each session, stimulation occurred for a time from about 8
to about 16 seconds, giving an average stimulation time of
about 11.25 seconds. At the end of each session, about 160
stimulations were given, which amounted to about 1,600
stimulations. Animals were ICMS mapped about 24 hours
following the final passive VNSsession.
Rats were shaped to the wheel spin task in about 4+0.3
sessions and the lever press task in about 4+0.3 sessions.
Rats reached the last stage of the wheel spin task in about
2725 sessions andthe lever press task in about 8+1 session.
The percent of successfully completed trials on the wheel
spin task on the first day of VNSpaired training was about
7724%. The same measure for the lever press task on the
first day of VNSpaired training was about 7824%. Micro-
electrode mapping techniques were used to determine the
organization of the motor cortex after five days of VNS
paired training on the last stage. Maps of the motor cortex
were derived from about 3,595 electrode penetrations (aver-
age about 103 sites per animal).
In all rats tested, the anterior portion of the motor map
generated movements of the rat’s head, including the jaw,
vibrissa, and neck. The middle region of the map generated
movements of the forelimb and the posterior region gener-
ated movements of the hindlimb.Asin earlier reports, it was
possible to divide the forelimb area into a small rostral
region that is mostly surrounded by head responses and a
larger caudal forelimb area that borders the hindlimb area.
In one embodiment, the organization of primary motor
cortex wasnot significantly altered by training without VNS.
The average area representing the distal forelimb, proximal
forelimb, head, and hindlimb were notsignificantly different
across the naive, wheel spin, or lever press trained rats that
had sham VNScuffs electrodes and received no VNS.As a
result, these three control groups are averaged for group
analyses and referred to as the non-VNS group.
In one embodiment, rats that received VNS paired with
the wheel spin task exhibited a significant reorganization of
the motor cortex. In the non-VNSrats, the head and distal
forelimb occupy approximately the same amountofcortical
area Hindlimb and proximal forelimb comprises a smaller
region of the motor map. Wheel spin/VNSpairing resulted
in an about 15% largerdistal forelimb area (about 1.0 mm”),
an about 25% smaller head area (about -1.75 mm”), and no
proximalforelimbarea in this particular animal compared to
the naive. These changes in cortical area for the Wheel
spin/VNSpaired group were pronounced when compared to
the non-VNS group. On average, pairing VNS with the
wheel spin task resulted in an about 32% increase in the
cortical area representing the distal forelimb comparedto the
non-VNS group. This increase was accompanied by an
about 38% smaller head area and an about 63% smaller
proximalforelimb area, but no change in the area devoted to
hindlimb. These results suggest that repeatedly pairing VNS
with a particular movement can generate a specific increase
in the motor cortex representation of that movement.
To confirm that the observed cortical plasticity was spe-
cific to the movementpaired with VNS, the reorganization
of motor cortex was documented in rats that recetved VNS
paired with a lever press task. Since this task primarily
involves movement of the proximal forelimb, an increased
proximalforelimb representation after lever press/VNSpatr-
ing was expected. The lever press/VNSrat had about 1600%
(about four mm?) more area devoted to the proximal fore-
limb area compared to the naive rat. Pairing VNS with the
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lever press movement reduced the head area by about 39%
(about -2.75 mm?) and distal forelimb area by about 59%
(about -4 mm?) in this rat compared to the naiverat. Like
the wheel spin/VNStrainedrat, the lever press/VNSrat had
the same sized hindlimb representation as the naive rat.
These examples suggest that the motor cortex plasticity
observed following VNS-movementpairing may be specific
to the paired movement and not a general effect of VNS.
On average, rats that recetved VNS during the lever task
exhibited about 159% increase in the proximal forelimb area
compared to the non-VNS group. The lever press/VNS
group had an about 23% smaller distal forelimb area and an
about 29% smaller head area than the non-VNSgroup. The
most profound differences were observed between the wheel
spin/VNSrats and the lever press/VNSrats. Although both
groups received identical VNS, wheel spin trained rats had
an about 72% larger distal forelimb area than the lever press
rats and the lever press rats had an about 598% larger
proximal forelimb area compared to the wheel spin trained
rats. These results may demonstrate that VNS-movement
pairing can generate large-scale reorganization of motor
cortex and confirm that the reorganization is specific to the
movementrepeatedly paired with VNS.
In one embodiment, VNS wasdelivered at random times
in two rats before documenting the organization of motor
cortex using ICMS techniques. Motor cortex in these rats
wassimilar to naive rats and there was no evidence of the
reorganizations that were observed after either the lever
press or the wheel spin movements were paired with VNS.
This observation combined with task specificity ofthe motor
cortex plasticity observed in the trained rats that received
VNSsuggests that VNS-movementpairing may be sufficient
to generate motor cortex reorganization.
Tn one embodiment, there was no difference in the average
stimulation thresholds for the groups receiving movement
paired VNS and the non-VNS group. The differences in
average stimulation thresholds between past studies and the
current study may be due to our using a somewhat deeper
level of anesthesia. The rats trained with VNS paired on the
wheel spin task had an average distal forelimb stimulation
threshold not too different from the wheel spin trained group
with sham VNScuff electrodes. The VNSpaired with lever
press group’s proximal upper forelimb stimulation thresh-
olds was not considerably different from the lever press
group trained with sham VNScuff electrodes. Similar stimu-
lation thresholds between paired-VNSand non-VNStrained
rats demonstrate that the observed movementrepresentation
reorganizationsare not dueto altered levels of excitability in
the cortex. This result is consistent with several papers that
have found cortical representation changes in the motor
cortex from training occurs without ICMS threshold
changes. Morphological changes, such as synaptogenesis,
have been observed with past motor cortical reorganization
accompanyingtraining and may account for a mechanism of
change in movement paired VNS.
The performance on the lever press task before and after
ischemic motor cortex damage in six rats was compared. In
one embodiment, performance was markedly impaired in
every rat. Average performancefell from 934+1% successful
double-tap attempts for the last two days before surgery to
75+5% for the two days of testing conducted after a week of
recovery. This result tends to confirm thatthis task like other
skilled motor tasks may depend on motor cortex for accurate
performance.
The task performance in each group was compared to
confirm that movement paired VNS does not make the task
more difficult. In one embodiment, no behavioral differences
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were observed between VNSand sham groups on the wheel
spin task in the total numberof successful trial, the velocity
at which the wheel was spun, or the percentage of success-
fully completed trials per session. VNS rats showed no
impairment on the lever press task and, in fact, exhibited
shorter lever press intervals andtriple pressed the lever more
often than the sham rats. Although VNS enhanced some
aspects ofthe lever press task,the percent of successfultrials
and the total number of successful trials were not different
between the VNS and sham rats. These results may indicate
that VNS is unlikely to have enhanced map reorganization
by making the task more difficult.
It was predicted that repeatedly pairing brief stimulation
of the vagus nerve with a specific movement would result in
a larger representation of that movementin the motorcortex.
As such, about 0.5 sec ofVNS wasdelivered each timerats
used their distal forelimb to rotate a wheel. After several
hundred pairings, the cortical representation of the distal
forelimb was markedly larger in these rats compared to
naive rats and rats that performed the same movements
without VNS. A second group ofrats was trained on a motor
task using a different part of their body to confirm that map
reorganization was specific to the movement paired with
VNS.Pairing VNS with a lever press task that required the
use of the proximal forelimb resulted in a markedly larger
proximal. Impaired performance in a group ofrats following
ischemic lesions to the caudal forelimb area tends to confirm
the involvement of the motor cortex in this task. The
observations that map expansion wasspecific to the move-
ment paired with VNS andthat neither of the tasks without
VNS nor VNS without the task training generated map
reorganization indicates that movement paired VNSis suf-
ficient to direct map plasticity.
Pairing VNS with a motor event generated cortical plas-
ticity comparable to that observed using a similar paradigm
in the auditory system. Presenting a tone with a brief period
of VNS causes a significant expansion of the paired tone’s
representation in the auditory cortex. Presenting tones or
VNS alone did not alter the auditory cortex’s tonotopic
organization. These two studies suggest that the plasticity
enhancing mechanisms of event-paired VNS maybe shared
with the auditory and motorcortex.
Anumberof studies have reported that training on skilled
motor tasks increases cortical representations for the move-
ments involved. The results disclosed herein do not contra-
dict these findings, as one of the landmark studies demon-
strating training induced cortical plasticity using a skilled
reaching task also demonstrated a lack of reorganization for
a lever press task. The lack of observed cortical change
following training on the lever press and wheel spin tasks
may be due to a numberof reasons. The cortical reorgani-
zation observedin a skilled reaching task has been attributed
to the accuracy of the movements necessary to complete the
task which may be absent in our lever press and wheel spin
tasks. There is also a possibility that the sampling distance
of about 500 um is too coarse to see cortical changes
associated with tasks in the current study, although this
spacing has previously demonstrated training inducedplas-
ticity in the aforementioned skilled reaching task. Another
possibility is the cortical changes observed following motor
and auditory learning have been shownto be transient while
the acquired skill remains stable over time. The lever press
and wheel spin trained rats were mapped approximately 10
and 20 days after their initial training session, respectively,
possibly occurring after cortical changes associated with
training would have been observed. If this possibility
US 9,522,272 B2
25
occurred, then the VNS-paired training may have prolonged
or reestablished the observed changes in the motor cortex
organization.
The exact mechanisms by which VNSdirectsplasticity in
motor or sensory cortex are unknown. VNS causes the
release of several molecules known to enhance cortical
plasticity, including acetylcholine, norepinephrine, sero-
tonin, and brain derived neurotrophic factor. Perfusing nor-
epinephrineinto an adult cat’s visual cortex produceskitten-
like plasticity in a test of ocular dominanceshifts following
monocular deprivation. Serotonin specific neurotoxins and
receptor blockers prevent normal ocular dominanceshifts in
kittens in monocular deprivation, implicating the importance
of serotonin for normal plasticity. Another important study
showed that enhancing serotonin release with fluoxetine can
stimulate plasticity in adult cats. Blocking the release of
acetylcholine prevents cortical plasticity and interferes with
skill learning and recovery from brain damage. The use of
the muscarinic antagonist scopolamine blocks the effect of
VNS on spontaneous firing rate in the auditory cortex,
further supporting the influence of VNS on the cholinergic
system. Adding brain derived neurotrophic factor induces
plastic changes in ocular dominance shifts in adult rats
following monocular deprivation. Combining more than one
of these elements can lead to greater plasticity than the
influence of the elements singularly. The ability of VNS
paired with wheel-spin or lever-press training to produce
cortical plasticity supports the importance of the VNStrig-
gered release of these molecules in enhancing cortical
plasticity. VNS is likely to generate cortical map plasticity
specific to the associated event through the synergistic
action of multiple plasticity enhancing molecules.
The simultaneous presentation of VNS with a specific
sensory or motor event can be sufficient to increase cortical
representation of that movement. As discussed above, a
sugar pellet was used to reward the animal’s behavior
immediately after the completion ofa trial. As a result, VNS
was delivered during the behavioral task that finished just a
few seconds prior to the animal eating the pellets. It would
not have been surprising to see an increased representation
of the head and jaw in this study.
In a previous study, our lab demonstrated that changes in
auditory cortex were temporally specific to tones paired with
VNS.Two randomly interleaved tones were presented every
about 15 to about 45 seconds for several thousandtrials to
a rat with only one of the tones paired with VNS. The
numberof sites responding to the VNSpaired tone increased
significantly, while the numberofsites for the tone presented
within tens of seconds of the VNS did not. These observa-
tions are consistent with past studies demonstrating that
pairing nucleus basalis stimulations with tones only alters
the tone’s representations when stimulations occurred
within seconds of the tone presentation.
The results disclosed herein demonstrate that the head
representations did not increase because ofVNSjustprior to
chewing. This result indicates that the plasticity enhancing
actions of VNS are temporally precise, lasting less than
about one or about two seconds. These results demonstrate
that brief pulses ofVNScan be usedto direct highly specific
plasticity. Additionally, VNS without paired behavioral
training did not result in map reorganization, further sup-
porting our conclusion that the cortical changes triggered by
VNSare enhanced by task specific pairing. Methods for
enhancing plasticity that rely on slow-acting mechanisms
may notbe as effective in generating the same accuracy of
plasticity as VNS-pairing. Pharmaceuticals often elevate or
diminish certain neurotransmitters for several hours. Several
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movements or sensory events may occur repeatedly during
this time, potentially creating unwanted plasticity. The tem-
poral precision of the VNS-pairing method for enhancing
cortical plasticity should offer advantages in efficiency and
efficacy as compared to methods with less precise actions.
In one embodiment, motor map expansions did not
accompany enhanced task performance inrats trained on the
VNS paired wheel spin or lever press tasks. This is not
necessarily at odds with the prediction that event paired
VNSincrease functional recovery through increasing func-
tional plasticity following cortical damage. Map reorgani-
zation has been shown to be important for enhancing behav-
ioral outcomes during the learning process (Reed et al.,
2011). Rats demonstrating increased tonotopic representa-
tions for low frequencies following paired nucleus basalis
stimulation demonstrated faster learning of a tone discrimi-
nation task compared to controls. However, rats that had
already learned the tone discrimination did not behaviorally
benefit from the induced plasticity. From these results, the
authors concluded that “cortical map expansion plays a
major role in perceptual learning but is not required to
maintain perceptual improvements”. In the present disclo-
sure, the rats had already learned the tasks when they began
receiving VNS, otherwise they may have demonstrated an
accelerated learning rate compared to the sham groups. The
enhanced propensity for cortical reorganization accompany-
ing event-paired VNS may increase rehabilitative learning.
Stroke and traumatic brain injury often damage move-
ment-controlling areas of the motor cortex resulting in
hemiparesis or hemiplegia. Following cortical injury, lost
motor representations can partially regenerate in neighbor-
ing areas within motor cortex. The size of the regenerated
representations is highly correlated with the functional
recovery of lost movements, but this recovered area and
ability is a fraction ofthose seen pre-injury. Physical training
in healthy animals can greatly increase cortical representa-
tion of the muscles used, during learning of the task, but
rehabilitative physical training in rats after a motor cortical
injury is less effective at generating this increased represen-
tation. Movement paired VNS in intact rats generates a
comparable amount of cortical plasticity in approximately
the same amount of time as physical training. Movement
paired VNSis also able to enhanceplasticity where plas-
ticity is not observed with training alone. Since increased
cortical plasticity is related to increased functional recovery
following cortical injury,it is possible that movementpaired
VNScould enhancethe recovery of specific motor functions
following cortical injury, comparedto rehabilitative training
alone.
Non-invasive brain stimulation techniques, such as
repeated transcranial magnetic stimulation and transcranial
direct current stimulation, show promise as methods for
inducing better functional recovery with rehabilitative train-
ing following stroke than training alone. These techniques
apply a localized current to the scalp to manipulate electrical
fields in the cortex without the need for surgery or pharma-
ceuticals. These methods are thought to work primarily
through influencing levels of cortical excitability, but also
cause increased levels of neurotrophic factors, serotonin,
and dopamine. Combining paired-VNS methods with non-
invasive brain stimulation may lead to even greater recovery
than either method used alone through activating different
plasticity enhancing mechanisms.
Periodic VNS is Food and Drug Administration (FDA)
approvedas a safe and effective treatmentofcertain types of
refractory epilepsy as well as treatment-resistant depression.
Protocols for treating epilepsy comprise about 30 seconds of
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VNSevery about five minutes, 24 hours per day. Periodic
VNS using a stimulation protocol similar to that used in
treating epilepsy has improved functional recovery in rats
with fluid percussion injury to the cortex. This protocol
requires about 145 times the daily current injection com-
pared to what was used in the method disclosed herein. The
above-disclosed results tend to demonstrate that motor and
auditory events can be precisely timed with VNS to mark-
edly alter motor and auditory system organization, respec-
tively. It seemslikely that therapies using paired VNS might
be a moreeffective therapy for increasing functional recov-
ery following cortical damage.
Selectively pairing VNS has already shown promise in
normalizing abnormalcortical organizations in the treatment
of tinnitus in rats. The overrepresentation of a tone was
reduced by pairing VNSwith tones spanning the rats hearing
range except for the tones near the tinnitus frequency. This
eliminated the behavioral correlate of tinnitus in rats for
several monthspast the cessation of the treatment. A similar
strategy of pairing VNS with movements may improve the
treatmentof disorders related to abnormalrepresentations in
the motor system, such as dystonias. Although the causes are
not fully understood, patients with dystonia demonstrate
disturbed cortical inhibition that is improved with the appli-
cation of transcranial magnetic stimulation. Current evi-
dence supports that reducing the overrepresented motor area
during these treatments is associated with a reduction in
dystonic symptoms. As disclosed herein, the larger repre-
sentations observed from the VNS paired movements were
accompanied by smaller nearby cortical representations,
such as movements of the head. Selectively increasing the
size of surrounding muscle representations might decrease
the overrepresentation of the dystonic muscles. Movement
paired VNS of non-dystonic, surrounding movements may
decrease the overrepresentation ofthe dystonic muscles. The
strategic pairing of non-dystonic movements with VNS
provides a novel potential therapy to treat focal dystonia.
Clinical and pre-clinical data has been collected to sup-
port the effectiveness of the tinnitus therapy and parameters.
Selection of the vagus nerve for stimulation is not arbi-
trary. The vagus nerve producesspecific effects when stimu-
lated at a specific time relative to a physical task. The
peripheral nervous system, central nervous system including
the brain and spinal cord are typically used by others as
therapeutic stimulation locations. The choice of stimulation
location largely determines the behavioral and neurophysi-
ologic outcome. Even though similar neural populations are
activated by input from two different locations, the manner
in which they are activated, for example, the pattern of
activity generated within the neuron population may depend
on the time course of activation, release of one or more
neuromodulators, attention state, etc. The neurophysiologi-
cal consequences therefore are bound to be different. Given
the large (and unknown) number of variables that can
influence the activation of a given neural population, the
mechanisms are likely to be complex and unpredictable.
There is no calculus to determine which locations may
produce which effects. Finding a location that produces a
given effect can only be done experimentally. It is not valid
to suggest that stimulation at one location makes it obvious
to stimulate at a different location, even if the goal is to
stimulate the same population of neurons.
The same can be said for stimulation parameters. At a
given stimulation location, stimulation according to one set
of parameters may not necessarily produce the same (or
similar) effects as a stimulation according to another set of
parameters. The frequency ofstimulation, the current ampli-
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tude of stimulation, the duration of each stimulation, the
waveform of stimulation, as well as other stimulation
parameters can change the results of stimulation.
Our experiments have shownthat the effect generated by
VNSpairing is very short, less than 15 seconds. A first tone
at a first frequency when paired with VNS generated an
increase in the numberofneurons that respondto the paired
frequency. A second unpaired tone at a second frequency,
played 15 seconds after the paired VNS did not show a
corresponding increase in the number of neurons that
respond to the second frequency. Nothing in the prior art
indicates this kind of precise timing requirement.
Similarly, we have performed experiments in which mul-
tiple tones at a given frequency were paired with VNS and
given 30 seconds apart. This was done in the tinnitus study
(Engineeret al., 2011) in which VNS waspaired with each
ofthe randomly interleaved tones every 30 seconds(e.g., 1.3
kilohertz (kHz)+VNS, then wait for 30 seconds, then give
6.3 kHz+VNS,and then wait for 30 seconds and so on). The
tones were selected such that they surrounded the tinnitus
frequency and the tinnitus frequency itself was excluded.
The idea was to shrink the representation of the tinnitus
frequency thereby restoring the map and synchronousactiv-
ity back to normal. When the same tones were presented
eight secondsapart, the effect was less than if the tones were
presented 30 seconds apart, which was surprising.
To cite another example, we have performed a series of
experiments where a tone is repeatedly paired with a foot-
shock to establish a conditioned fear response. Subse-
quently, when the tone was presented without a foot-shock,
the rat would freeze, anticipating a foot shock. If the tone,
withoutthe foot-shock, is then presented repeatedly, the fear
caused by the tone would eventually be extinguished, undo-
ing the conditioning. By pairing the tone (without the
foot-shock) with VNS,the fear is extinguished much more
quickly. However, presenting the tone by itself and then
giving VNS minutes later, the fear is extinguished at the
normalrate.
Further experiments have demonstrated the effect of the
described therapy. VNS paired with a movement improves
motor performancein a rat model of ischemic stroke. VNS
paired with movement improves a motor deficit several
weeks after an ischemic lesion. VNS delivered two hours
after rehabilitation did not show any significant difference
from rehabilitation alone.
These results demonstrate that the precise timing between
VNSand the event as well as the interval separating the
VNS-event pairings appear to be important for inducing
highly specific plasticity.
Neurostimulation does not behave in a predictable fash-
ion. Different stimulation locations produce different results,
even when both locations are cranial nerves. For example,
synchronization in the cerebral cortex is a manifestation of
epilepsy. Stimulating the vagus nerve causes desynchroni-
zation of the cortex neurons, which has been proposed as a
potential mechanism for how vagusstimulation prevents an
epileptic seizure. Stimulation of the trigeminal nerve,
another cranial nerve, causes desynchronization as well. To
determine whetherthe plasticity induced by VNSis specific
to the vagus nerve, we paired stimulation of the trigeminal
nerve with a 19 kHz tone. However, when we paired
trigeminal stimulation with a tone, in the same way we
paired VNS with a tone, we did not observe anyplasticity
that was specific to the paired tone. Pairing the trigeminal
stimulation with a tone at a given frequency did not change
the response to that frequency even though it caused desyn-
chronization like in the previous study. Each stimulation
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location is unique acrossthe full range ofeffects. It appears
that VNS may be uniquely suited to direct cortical plasticity
and suggests that the vagus nerveis likely a key conduit by
which the autonomic nervous system informs the central
nervous system of important stimuli.
Both VNSpairing and nucleus basalis stimulation (NBS)
pairing have been shown to change the number of neurons
respondingto a paired frequency. To be effective, the current
amplitude parameter of the stimulation for VNSpairing is
more than twice the current amplitude used for NBSpairing.
There is an important difference between the neuromodula-
tors released by NBS from those released by VNS, so
significant differences between the results of NBS and VNS
are expected.
Another experiment demonstrated that pairing a single
tone at a specified frequency with VNSincreased the num-
ber of neurons responding not only to that frequency but to
close frequencies, e.g., increased the bandwidth compared to
control rats. For NBS pairing, the bandwidth was not
significantly different from control rats. Unlike VNSpairing,
NBSpairing is highly invasive and may be unsuitable to
provide a practical therapeutic benefit. Similar results in one
circumstance cannot be extendedto predict similar results in
another, even slightly different, circumstance. Different
stimulation parameters have to be used for effective VNS
pairing and NBSpairing.
Because of the specific neurotransmitter mechanismsthat
generate the specific plasticity required for the described
therapies, some drugs may reduce the effectiveness. Mus-
carinic antagonists, norepinephrine blockers that are cen-
trally acting, norepinephrine uptake inhibitors, nicotinic
antagonists, Selective serotonin reuptake inhibitors, drugs
that block serotonin and drugs that block dopamine mayall
reduce the effectiveness of the paired VNStherapies.
None of the description in the present application should
be read as implying that any particular element, step, or
function is an essential element that must be included in the
claim scope: the scope of patented subject matter is defined
only by the allowed claims. Moreover, none of these claims
is intended to invoke paragraph six of 35 U.S.C.section 112
unless the exact words “means for” are followed by a
participle. The claims as filed are intended to be as com-
prehensiveas possible, and no subject matter is intentionally
relinquished, dedicated, or abandoned.
At least one embodiment is disclosed and variations,
combinations, and/or modifications of the embodiment(s)
and/or features of the embodiment(s) made by a person
having ordinary skill in the art are within the scope of the
disclosure. Alternative embodiments that result from com-
bining, integrating, and/or omitting features of the embodi-
ment(s) are also within the scope of the disclosure. Where
numerical ranges or limitations are expressly stated, such
express ranges or limitations should be understood to
include iterative ranges or limitations of like magnitude
falling within the expressly stated rangesor limitations(e.g.,
from about 1 to about 10 includes, 2, 5, 4, etc.; greater than
0.10 includes 0.11, 0.12, 0.15, etc.). For example, whenever
a numerical range with a lower limit, R,, and an upperlimit,
R,,, 1s disclosed, any number falling within the range is
specifically disclosed. In particular, the following numbers
within the range are specifically disclosed: R=R,+k*(R,,-
R,), wherein k is a variable ranging from 1 percent to 100
percent with a 1 percent increment, i.e., k is 1 percent, 2
percent, 5 percent, 4 percent, 5 percent, ... , 50 percent, 51
percent, 52 percent, ..., 75 percent, 76 percent, 77 percent,
78 percent, 77 percent, or 100 percent. Moreover, any
numerical range defined by two R numbersas defined in the
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aboveis also specifically disclosed. Use of the term “about”
means+10% of the subsequent number, unless otherwise
stated herein. Use of the term “optionally” with respect to
any element of a claim means that the element is required,
or alternatively, the elementis not required, both alternatives
being within the scope of the claim. Use of broader terms
such as comprises, includes, and having should be under-
stood to provide support for narrower terms such as con-
sisting of, consisting essentially of, and comprised substan-
tially of. Accordingly, the scope of protection is not limited
by the description set out above but is defined by the claims
that follow, that scope including all equivalents of the
subject matter of the claims. Each and every claim is
incorporated as further disclosure into the specification and
the claims are embodiment(s) of the present disclosure. The
discussion of a reference in the disclosure is not an admis-
sion that it is prior art, especially any reference that has a
publication date after the priority date of this application.
The disclosure of all patents, patent applications, and pub-
lications cited in the disclosure are hereby incorporated by
reference, to the extent that they provide exemplary, proce-
dural, or other details supplementary to the disclosure.
While several embodiments have been provided in the
present disclosure, it should be understoodthat the disclosed
systems and methods might be embodied in many other
specific forms without departing from the spirit or scope of
the present disclosure. The present examples are to be
considered as illustrative and not restrictive, and the inten-
tion is not to be limited to the details given herein. For
example, the various elements or components may be com-
bined or integrated in another system or certain features may
be omitted, or not implemented.
In addition, techniques, systems, subsystems, and meth-
ods described and illustrated in the various embodiments as
discrete or separate may be combined or integrated with
other systems, modules, techniques, or methods without
departing from the scope of the present disclosure. Other
items shown or discussed as coupled or directly coupled or
communicating with each other maybeindirectly coupled or
communicating through some interface, device, or interme-
diate component whetherelectrically, mechanically, or oth-
erwise. Other examples of changes, substitutions, and altera-
tions are ascertainable by one skilled in the art and could be
made without departing from the spirit and scope disclosed
herein.
Whatis claimedis:
1. A method of improving motor deficits in a stroke
patient, comprising:
assessing a stroke patient’s motor deficits;
determining therapeutic goals for the patient, based on the
patient’s motor deficits;
selecting one or more therapeutic tasks based on the
therapeutic goals;
observing repetitive performances by the patient of the
selected therapeutic task;
stimulating the vagus nerve of the patient with an
implanted neurostimulator that delivers pulse trains of
electrical stimulation energy to a vagus nerve while the
patient is performing a movement of the selected
therapeutic task;
terminating the stimulation of the vagus nerve so that
there is no stimulation between movement execution;
and
improving the patient’s motor deficits,
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wherein the pulse trains are delivered for a period of time
during the movement, and the period of time has a
duration that is different than a duration of the move-
ment.
2. The method of claim 1, wherein the pulse trains are
about 500 milliseconds in duration.
3. The method of claim 1, wherein the pulse trains have
an amplitude of about 0.8 milliamperes.
4. The method of claim 1, wherein the pulse trains are no
longer than about 500 milliseconds in duration.
5. The method of claim 1, further comprising operating
the implanted neurostimulator to deliver pulse trains of
electrical stimulation energy to the vagus nerve such that a
pulse train results in respective directed neuro plasticity
lasting no more than about 8 seconds.
6. The method of claim 1, wherein the pulse trains have
a current of no more than about 0.8 milliamperes.
7. The method of claim 1, wherein the pulse trains have
a current of no less than about 0.8 milliamperes.
8. The method of claim 1, wherein the action of stimu-
lating the vagus nerve of the patient further comprises
automatically sensing respective performances of the
selected therapeutic task, and applyingthe pulse trains to the
vagus nerve based on the sensed beginnings of the perfor-
mances.
9. The method of claim 1, wherein the vagus nerve
stimulation pulse train is not presented between perfor-
mancesof the selected skilled motor task.
10. The method of claim 1, further comprising operating
the implanted neurostimulator to deliver pulse trains of
electrical stimulation energy to the vagus nerve such that
respective pulse trains of the delivered pulse trains results in
respective directed neuro plasticity lasting no more than
about 8 seconds.
11. A method of improving motor deficits in a stroke
patient, comprising:
assessing a stroke patient’s motor deficits; determining
therapeutic goals for the patient, based on the patient’s
motordeficits; selecting a therapeutic task based on the
therapeutic goals;
detecting motion during repetitive performances by the
patient of the selected therapeutic task;
automatically stimulating a vagus nerve of the patient
with an implanted neurostimulator that delivers pulse
trains of electrical stimulation energy to the vagus
nerve when a predetermined motion is detected;
ending the stimulation of the vagus nerve so that there is
no stimulation between the repetitive performances;
and
improving the patient’s motor deficits,
wherein the pulse trains are delivered for a period of time
during the predetermined motion, and the period of
time has a duration that is different than a duration of
the predetermined motion.
12. The method of claim 11, wherein the pulse trains are
about 500 milliseconds in duration.
13. The method of claim 11, wherein the pulse trains have
an amplitude of about 0.8 milliamperes.
14. The method of claim 11, wherein the motion is
detected by detecting change in color of an object by a
camera, wherein the object is supported by the patient.
15. The method of claim 11, wherein the action of
automatically stimulating the vagus nerve of the patient is
executed such that a pulse train results in respective directed
neuro plasticity lasting no more than about 8 seconds.
16. The method of claim 11, wherein the action of
automatically stimulating the vagus nerve of the patient is
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executed such that respective pulse trains of the delivered
pulse trains results in respective directed neuro plasticity
lasting no more than about 8 seconds.
17. A system for providing therapy for a motor deficit,
comprising:
an implantable stimulation system comprising an implant-
able pulse generator, an electrode and a lead coupling
the implantable pulse generator to the electrodes,
wherein the implantable stimulation system stimulates
a patient’s vagus nerve with at least one pulse train
having a duration of about 500 milliseconds;
a clinical controller comprising a processor, stimulation
control software, manual interfaces and a display;
an external communication device configured to commu-
nicate between the clinical controller and the implant-
able stimulation system; and
a manual input device configured to communicate with
the clinical controller,
wherein the manual input device is configured to be engaged
during performanceofa therapeutic task causing the clinical
controller to send a signal through the external communi-
cation device to the implantable stimulation system, so that
the patient’s vagus nerve is stimulated during the perfor-
mance ofthe therapeutic task.
18. The system of claim 17, further comprising a hand
held control magnet configured to communicate with the
implantable stimulation system.
19. The system of claim 17, wherein the implantable
stimulation system is configured to stimulate the patient’s
vagus nerve with a pulsetrain thatis about 0.8 milliamperes.
20. A system for providing automated therapy for a motor
deficit, comprising:
an implantable stimulation system comprising an implant-
able pulse generator, an electrode and a lead coupling
the implantable pulse generator to the electrode,
wherein the implantable stimulation system stimulates
a patient’s vagus nerve;
a clinical controller comprising a processor, stimulation
control software, manual interfaces and a display;
an external communication device configured to commu-
nicate between the clinical controller and the implant-
able stimulation system;
a task object, configured to be used in performance of a
therapeutic task;
a colored marker, configured to attach to the task object
and having a predetermined color; and
a motion detector, configured to be coupled to the clinical
controller;
wherein using data generated by the motion detector, the
clinical controller is configuredto identify a starting location
of the colored marker, detects motion of the colored marker
associated with performance of the therapeutic task and
generates communication with the implantable stimulation
system so that the patient’s vagus nerveis stimulated during
the performanceofthe therapeutic task by at least one pulse
train having a duration less than a duration of the therapeutic
task.
21. The system of claim 20 wherein the motion detector
is a digital camera.
22. The system ofclaim 20, wherein the clinical controller
is configured to calculate displacement of the object to
trigger stimulation.
23. The system of claim 20 wherein the clinical controller
is configured to calculate speed of motion to trigger stimu-
lation.
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24. The system of claim 20, further comprising a manual
interrupt configured to couple to the clinical controller,
wherein the manual interrupt prevents stimulation when
engaged.
25. The system of claim 20, further comprising a manual
interrupt configured to couple to the clinical controller,
wherein the manual interrupt allows stimulation when
released.
26. The system of claim 20 wherein the clinical controller
is configured to calculate change in height of the object to
trigger stimulation.
27. The system of claim 20 wherein the clinical controller
is configured to calculate rotation of the object to trigger
stimulation.
28. The system ofclaim 20, wherein the clinical controller
is configured to calculate acceleration of motion to trigger
stimulation.
29. The system of claim 20, wherein the motion detector
is configured to detect changes in color of the object by a
camera.
30. The system of claim 20, wherein the implantable
stimulation system is configured to stimulate the patient’s
vagus nerve with a pulse train that is about 500 milliseconds
in duration.
31. The system of claim 20, wherein the implantable
stimulation system is configured to stimulate the patient’s
vagus nerve with a pulsetrain that is about 0.8 milliamperes.
* * * * *
10
15
20
25
34
